Association of the rs1424954 polymorphism of the ACVR2A gene with the risk of pre-eclampsia is not replicated in a Finnish study population

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Lokki, A Inkeri ^a,b   Klemetti, Miira M ^b,c   Heino, Sanna ^a,b   Hiltunen, Leena ^d   Heinonen, Seppo ^e,f   Laivuori, Hannele ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Activin A; ACVR2A; Pre eclampsia; SNP

Indexed keywords

EID: 83655191645     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-545     Document Type: Article

References (28)

1. Epidemiological studies on primipaternity and immunology in preeclampsia - a statement after twelve years of workshops. Robillard PY, Dekker G, Chaouat G, Hulsey TC, Saftlas A, J Reprod Immunol 2011 89 2 104 117 10.1016/j.jri.2011. 02.003 21543120
2. Summary of the NHLBI working group on research on hypertension during pregnancy. Roberts JM, Pearson G, Cutler J, Lindheimer M, Hypertension 2003 41 3 437 445 10.1161/01.HYP.0000054981.03589.E9 12623940 (Pubitemid 36314613)
3. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Bellamy L, Casas J, Hingorani AD, Williams DJ, BMJ 2007 335 7627 974 10.1136/bmj.39335.385301.BE 17975258 (Pubitemid 350144670)
4. TGF-{beta} superfamily expression and actions in the endometrium and placenta. Jones RL, Stoikos C, Findlay JK, Salamonsen LA, Reproduction 2006 132 2 217 232 10.1530/rep.1.01076 16885531 (Pubitemid 44269704)
5. Reviews: activins and related proteins in the establishment of pregnancy. Florio P, Gabbanini M, Borges LE, Bonaccorsi L, Pinzauti S, Reis FM, Boy Torres P, Rago G, Litta P, Petraglia F, Reprod Sci 2010 17 4 320 330 10.1177/1933719109353205 20228378
6. Gene Expression Profiling of Placentas Affected by Pre-Eclampsia. Hoegh AM, Borup R, Nielsen FC, Sørensen S, Hviid TVF, J Biomed Biotechnol 2010 2010 11 Article ID 787545
7. Activin and related proteins in inflammation: not just interested bystanders. Phillips DJ, de Kretser DM, Hedger MP, Cytokine Growth Factor Rev 2009 20 2 153 164 10.1016/j.cytogfr.2009.02.007 19261538
8. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Breit S, Ashman K, Wilting J, Rössler J, Hatzi E, Fotsis T, Schweigerer L, Cancer Res 2000 60 16 4596 4601 10969812 (Pubitemid 32103645)
9. Expression of the type II activin receptor gene in the human placenta. Peng C, Huang T, Jeung E, Donaldson C, Vale W, Leung P, Endocrinology 1993 133 6 3046 3049 10.1210/en.133.6.3046 8243335 (Pubitemid 24000772)
10. The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour. Schneider-Kolsky ME, Manuelpillai U, Waldron K, Dole A, Wallace EM, Placenta 2002 23 4 294 302 10.1053/plac.2002.0787 11969340 (Pubitemid 41348522)
11. Assignment of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2-q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH. Bondestam J, Horelli-Kuitunen N, Hildén K, Ritvos O, Aaltonen J, Cytogenet Cell Genet 1999 87 3-4 219 220 10.1159/000015429 10702675 (Pubitemid 30103096)
12. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S, Am J Med Genet 2000 91 4 256 260 10.1002/(SICI)1096-8628(20000410)91: 4<256::AID-AJMG3>3.0.CO;2-T 10766979 (Pubitemid 30191247)
13. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population-based Swedish cohort study. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P, Am J Med Genet Part A 2004 130A 4 365 371 10.1002/ajmg.a.30257 15384082 (Pubitemid 39441611)
14. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Moses EK, Lade JA, Guo GL, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW, Brennecke SP, Am J Hum Genet 2000 67 6 1581 1585 10.1086/316888 11035632
15. A Genome-Wide Scan Reveals a Maternal Susceptibility Locus for Pre-Eclampsia on Chromosome 2p13. Arngrímsson R, Siguráará áttir S, Frigge ML, Bjarnaááttir RI, Jánsson T, Stefánsson H, Baldursdáttir Á Einarsdáttir AS, Palsson B, Snorradôttir S, Lachmeijer AMA, Nicolae D, Kong A, Bragason BT, Gulcher JR, Geirsson RT, Stefánsson K, Hum Mol Genet 1999 8 9 1799 1805 10.1093/hmg/8.9.1799 10441346 (Pubitemid 29423892)
16. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Moses EK, Fitzpatrick E, Freed KA, Dyer TD, Forrest S, Elliott K, Johnson MP, Blangero J, Brennecke SP, Mol Hum Reprod 2006 12 8 505 512 10.1093/molehr/gal056 16809377 (Pubitemid 44288196)
17. Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity. Laivuori H, Kaaja R, Turpeinen U, Stenman U, Ylikorkala O, BJOG: Int J Obstet Gynaecol 1999 106 12 1298 1303 10.1111/j.1471-0528.1999. tb08185.x
18. The study of inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index to predict pre-eclampsia. Yu J, Shixia C, Wu Y, Duan T, Ultrasound Obst Gynecol 2010 37 5 528 533
19. Potential anti-inflammatory role of activin A in acute coronary syndromes. Smith C, Yndestad A, Halvorsen B, Ueland T, Wæhre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Frøland SS, Damås JK, Aukrust P, J Am Coll Cardiol 2004 44 2 369 375 10.1016/j.jacc.2004.03.069 15261933 (Pubitemid 38950596)
20. Characteristic of recent fetal growth curves in Finland. Pihkala J, Hakala T, Voutilainen P, Raivio K, Duodecim 1989 105 18 1540 1546 2680445
21. A population-based nested case-control study. Hiltunen L, Laivuori H, Rautanen A, Kaaja R, Kere J, Krusius T, Paunio M, Rasi V, Blood group AB and factor V Leiden as risk factors for preeclampsia, Thromb Res 2009 124 2 167 173 10.1016/j.thromres.2008.11.012 19110300
22. ACOG practice bulletin, Diagnosis and management of preeclampsia and eclampsia. ACOG Committee on Obstetric Practice, Int J Gynaecol Obstet 2002 77 1 67 75 12094777
23. 677 C > T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K, Obstet Gynecol 2000 96 2 277 280 10.1016/S0029-7844(00)00896-6 10908777 (Pubitemid 30447353)
24. Tumour necrosis factor- gene haplotype is associated with pre-eclampsia. Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M, Mol Hum Reprod 2005 11 6 437 440 10.1093/molehr/gah182 15901845 (Pubitemid 41418068)
25. Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies. Rodriguez S, Gaunt TR, Day INM, American Journal of Epidemiology 2009 169 4 505 514 19126586
26. Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia. Fitzpatrick E, Johnson MP, Dyer TD, Forrest S, Elliott K, Blangero J, Brennecke SP, Moses EK, Mol Hum Reprod 2009 15 3 195 204 10.1093/molehr/gap001 19126782
27. Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Roten LT, Johnson MP, Forsmo S, Fitzpatrick E, Dyer TD, Brennecke SP, Blangero J, Moses EK, Austgulen R, Eur J Hum Genet 2009 17 2 250 257 10.1038/ejhg.2008.158 18781190
28. The genome-wide patterns of variation expose significant substructure in a founder population. Jakkula E, Rehnström K, Varilo T, Pietiläinen OPH, Paunio T, Pedersen NL, deFaire U, Järvelin M, Saharinen J, Freimer N, Ripatti S, Purcell S, Collins A, Daly MJ, Palotie A, Peltonen L, Am J Hum Genet 2008 83 6 787 794 10.1016/j.ajhg.2008.11.005 19061986